22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

Home
About Us
Reduced Nicotine Tobacco
- VLN®
- Clinical Studies & Commentaries
Hemp/Cannabis Innovation
- GVB Biopharma
Hops Research
News
Investors
Contact Us

Events

Investors

Overview
New Investor / Latest Resources
Events
News
- Press Releases
Stock Data
- Quote
- Charts
- Historical Data
- Trades
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs

LD Micro Invitational XII

Four Seasons Hotel, Westlake Village, CA

Jun 7, 2022 8:00 am PDT

Webcast

Email Alerts
Contact
RSS News Feed

© 2022 22nd Century Group, Inc. All Rights Reserved.

Privacy Policy / CCPA Disclaimer Sitemap